Wellington Management Group LLP Cytokinetics Inc Transaction History
Wellington Management Group LLP
- $529 Billion
- Q2 2025
A detailed history of Wellington Management Group LLP transactions in Cytokinetics Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 7,827,679 shares of CYTK stock, worth $498 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
7,827,679
Previous 7,988,740
2.02%
Holding current value
$498 Million
Previous $321 Million
19.45%
% of portfolio
0.05%
Previous 0.06%
Shares
21 transactions
Others Institutions Holding CYTK
# of Institutions
385Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.12 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$933 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$762 Million0.01% of portfolio
-
State Street Corp Boston, MA6.37MShares$405 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.65MShares$232 Million4.28% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.99B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...